These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6861865)

  • 1. Pharmacokinetics in man of a new antiarrhythmic drug, cibenzoline.
    Canal M; Flouvat B; Tremblay D; Dufour A
    Eur J Clin Pharmacol; 1983; 24(4):509-15. PubMed ID: 6861865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cibenzoline in patients with renal impairment.
    Canal M; Flouvat B; Aubert P; Guedon J; Prinseau J; Baglin A
    J Clin Pharmacol; 1985 Apr; 25(3):197-203. PubMed ID: 3998200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-dose pharmacokinetics and dose proportionality of oral cibenzoline.
    Khoo KC; Szuna AJ; Colburn WA; Aogaichi K; Morganroth J; Brazzell RK
    J Clin Pharmacol; 1984 Jul; 24(7):283-8. PubMed ID: 6480874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The disposition and metabolic fate of 14C-cibenzoline in man.
    Massarella JW; Loh AC; Williams TH; Szuna AJ; Sandor D; Bressler R; Leinweber FJ
    Drug Metab Dispos; 1986; 14(1):59-64. PubMed ID: 2868867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of renal impairment on the pharmacokinetics of cibenzoline.
    Massarella JW; Khoo KC; Aogaichi K; Di Persio D; Smith M; Kluger J; Chow MS
    Clin Pharmacol Ther; 1988 Mar; 43(3):317-23. PubMed ID: 3345622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of intravenous cibenzoline in normal volunteers.
    Brazzell RK; Khoo KC; Szuna AJ; Sandor D; Aogaichi K; Wills RJ
    J Clin Pharmacol; 1985 Sep; 25(6):418-23. PubMed ID: 4056077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetic study of a new antiarrhythmic drug, cibenzoline, during the acute phase of myocardial infarction. Therapeutic correlations].
    Desoutter P; Dufour A; Aymard MF; Haiat R
    Therapie; 1983; 38(3):237-45. PubMed ID: 6612660
    [No Abstract]   [Full Text] [Related]  

  • 8. Electrophysiologic effects, antiarrhythmic activity and pharmacokinetics of cibenzoline studied with programmed stimulation of the heart in patients with supraventricular reentrant tachycardias.
    Waleffe A; Dufour A; Aymard MF; Kulbertus H
    Eur Heart J; 1985 Mar; 6(3):253-60. PubMed ID: 4029182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age and cibenzoline disposition.
    Brazzell RK; Rees MM; Khoo KC; Szuna AJ; Sandor D; Hannigan J
    Clin Pharmacol Ther; 1984 Nov; 36(5):613-9. PubMed ID: 6488682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and kinetics of cibenzoline in patients with normal and impaired renal function.
    Aronoff G; Brier M; Mayer ML; Barbalas M; Aogaichi K; Sloan R; Brazzell R; Massarella J
    J Clin Pharmacol; 1991 Jan; 31(1):38-44. PubMed ID: 2045527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fate of SU-13197, a new antiarrhythmic drug, in rat and man.
    Shand DG; Cavanaugh JH; Oates JA
    Clin Pharmacol Ther; 1971; 12(5):769-78. PubMed ID: 5568258
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of oral cibenzoline in arrhythmia patients.
    Brazzell RK; Colburn WA; Aogaichi K; Szuna AJ; Somberg JC; Carliner N; Heger J; Morganroth J; Winkle RA; Block P
    Clin Pharmacokinet; 1985; 10(2):178-86. PubMed ID: 3995859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac electrophysiological effects of cibenzoline by acute and chronic administration in the anesthetized dog.
    Sassine A; Massé C; Dufour A; Hirsch JL; Cazes M; Puech P
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):201-18. PubMed ID: 6476979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiarrhythmic effects of cibenzoline.
    Miura DS; Keren G; Torres V; Butler B; Aogaichi K; Somberg JC
    Am Heart J; 1985 Apr; 109(4):827-33. PubMed ID: 3984837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of oral administration of cibenzoline and digoxin in patients with supraventricular arrhythmia].
    Garnier LF; Bine-Scheck F; Pruvost P; Wanszelbaum H; Arnaud R
    Ann Cardiol Angeiol (Paris); 1992 Sep; 41(7):411-7. PubMed ID: 1285630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oxmetidine, a new histamine H2-receptor antagonist, after single oral and intravenous doses.
    Jönsson KA; Bodemar G; Gotthard R; Norlander B; Walan A
    Eur J Clin Pharmacol; 1983; 24(3):353-6. PubMed ID: 6134622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biotransformation of cibenzoline to 2-(2,2-diphenylcyclopropyl)-1H-imidazole.
    Leinweber FJ; Loh AC; Szuna AJ; Carbone JJ; Williams TH; Sasso GJ; Tilley JW; Pace D; Dahlen P; Kovacs JL
    Xenobiotica; 1983 May; 13(5):287-94. PubMed ID: 6636825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of cibenzoline after single and repetitive dosing in healthy volunteers.
    Massarella JW; Khoo KC; Szuna AJ; Sandor DA; Morganroth J; Aogaichi K
    J Clin Pharmacol; 1986 Feb; 26(2):125-30. PubMed ID: 3950056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of oral cibenzoline on steady-state digoxin concentrations in healthy volunteers.
    Khoo KC; Givens SV; Parsonnet M; Massarella JW
    J Clin Pharmacol; 1988 Jan; 28(1):29-35. PubMed ID: 3350991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Injectable and oral cibenzoline in the treatment of supraventricular tachycardia related to intranodal reentry or accessory atrioventricular conduction pathway].
    Fauchier JP; Rouesnel P; Breuillac JC; Cosnay P; Scheck F; Garnier LF
    Ann Cardiol Angeiol (Paris); 1994 Apr; 43(4):194-203. PubMed ID: 8024234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.